Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mohamed Abdel-Gabbar"'
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 11, Iss 1, Pp 1-10 (2022)
Abstract Background The long-term effects of diabetes mellitus (DM) can impair several organs, including the kidney, resulting in serious health problems. Diabetic nephropathy (DN), a primary contributor in end-stage renal failure worldwide, affects
Externí odkaz:
https://doaj.org/article/e554f8c7212c44f1a4c28f240b02a323
Autor:
Asmaa S. Zaky, Mohamed Kandeil, Mohamed Abdel-Gabbar, Eman M. Fahmy, Mazen M. Almehmadi, Tarek M. Ali, Osama M. Ahmed
Publikováno v:
Pharmaceutics, Vol 14, Iss 2, p 263 (2022)
Diabetes mellitus (DM) is a chronic metabolic disorder that threatens human health. Medicinal plants have been a source of wide varieties of pharmacologically active constituents and used extensively as crude extracts or as pure compounds for treatin
Externí odkaz:
https://doaj.org/article/f1c8a7b4f3aa41f888e95d2dc03e85b9
Autor:
Yasmine A. Ali, Hanan A. Soliman, Mohamed Abdel-Gabbar, Noha A. Ahmed, Kandil A. A. Attia, Fatma M. Shalaby, El-Shaymaa El-Nahass, Osama M. Ahmed
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2023:1-17
Paclitaxel, one of the most effective chemotherapeutic drugs, is used to treat various cancers but it is exceedingly toxic when used long-term and can harm the liver. This study aimed to see if rutin, hesperidin, and their combination could protect m
Autor:
Yasmine A. Ali, Osama M. Ahmed, Hanan A. Soliman, Mohamed Abdel-Gabbar, M. Al-Dossari, N. S. Abd El-Gawaad, El-Shaymaa El-Nahass, Noha A. Ahmed
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2023:1-15
Paclitaxel is a primary chemotherapy agent that displays antitumor activity against a variety of solid tumors. However, the clinical effectiveness of the drug is hampered by its nephrotoxic and cardiotoxic side effects. Thus, this investigation aimed
Autor:
Sanaa M. Abd El-Twab, Kamal A. Amin, Osama M. Ahmed, Mohamed Abdel-Gabbar, Hessah Mohammed Al-Muzafar, Sarah M. Abdel Aziz
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
The present study aimed to evaluate the antihyperglycemic effects of Musa paradisiaca (M. paradisiaca) leaf and fruit peel hydroethanolic extracts and to suggest their probable mode of actions in nicotinamide (NA)/streptozotocin (STZ)-induced diabeti
Autor:
Hanan Fathy Hammouda, Mohammad Mahmoud Farag, Mervet M.F. El Deftar, Mohamed Abdel-Gabbar, Basant M. Mohamed
Publikováno v:
Advances in Animal and Veterinary Sciences. 10
Autor:
Asmaa S, Zaky, Mohamed, Kandeil, Mohamed, Abdel-Gabbar, Eman M, Fahmy, Mazen M, Almehmadi, Tarek M, Ali, Osama M, Ahmed
Publikováno v:
Pharmaceutics. 14(2)
Diabetes mellitus (DM) is a chronic metabolic disorder that threatens human health. Medicinal plants have been a source of wide varieties of pharmacologically active constituents and used extensively as crude extracts or as pure compounds for treatin
Autor:
Alaa M, Ali, Mohamed Abdel, Gabbar, Sanaa M, Abdel-Twab, Eman M, Fahmy, Hossam, Ebaid, Ibrahim M, Alhazza, Osama M, Ahmed
Publikováno v:
Oxidative Medicine and Cellular Longevity
This study is aimed at assessing the antihyperglycemic, antihyperlipidemic, and antioxidant effects of Citrus reticulata (C. reticulata) fruit peel hydroethanolic extract and two flavonoids, hesperidin and quercetin, in nicotinamide (NA)/streptozotoc
Autor:
Mohamed Abdel-Gabbar, Mohamed I. Zanaty, Adel Abdel-Moneim, Alaa Aboud, Mohamed Ramadan, Amr A Abd Elbary
Publikováno v:
Annals of Gastroenterology
Background The discovery of direct-acting antiviral agents (DAA) is an outstanding achievement of modern medicine in the current century. The current study aimed to explore the effectiveness and safety of two regimens sofosbuvir (SOF) in combination
Publikováno v:
Digestive Diseases and Sciences. 63:1341-1347
The current standard of care for patients with chronic hepatitis C virus (HCV) infection is a combination of direct-acting antiviral agents (DAAs). However, rare clinical trials have been reported on the combination regimen of sofosbuvir (SOF) with o